Growth Metrics

Pacific Biosciences Of California (PACB) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.69%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -4.08%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 12.94%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 26.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 59.09%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 31.63%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn -51.54%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -51.54%
Dec 31, 2025 -40.20%
Sep 30, 2025 -39.84%
Jun 30, 2025 -30.92%
Mar 31, 2025 -52.88%
Dec 31, 2024 -3.32%
Sep 30, 2024 -7.27%
Jun 30, 2024 -3.76%
Mar 31, 2024 8.76%
Dec 31, 2023 -7.64%
Sep 30, 2023 3.99%
Jun 30, 2023 -5.93%
Mar 31, 2023 -20.93%
Dec 31, 2022 -5.19%
Sep 30, 2022 0.19%
Jun 30, 2022 20.34%
Mar 31, 2022 123.34%
Dec 31, 2021 259.01%
Sep 20, 2021 278.61%
Jun 30, 2021 388.71%
Mar 31, 2021 152.11%
Dec 31, 2020 36.34%
Sep 30, 2020 22.90%
Jun 30, 2020 -20.91%
Mar 31, 2020 -7.97%
Dec 31, 2019 -48.56%
Sep 30, 2019 -20.74%
Jun 30, 2019 -21.73%
Mar 31, 2019 -17.06%
Dec 31, 2018 39.55%
Sep 30, 2018 3.16%
Jun 30, 2018 4.29%
Mar 31, 2018 5.98%
Dec 31, 2017 11.46%
Sep 30, 2017 -2.72%
Jun 30, 2017 -0.58%
Mar 31, 2017 8.80%
Dec 31, 2016 20.09%
Sep 30, 2016 57.72%
Jun 30, 2016 51.75%
Mar 31, 2016 40.74%
Dec 31, 2015 34.28%
Sep 30, 2015 32.06%
Jun 30, 2015 49.41%
Mar 31, 2015 43.39%
Dec 31, 2014 17.89%
Sep 30, 2014 12.94%
Jun 30, 2014 -9.08%
Mar 31, 2014 -17.33%
Dec 31, 2013 -0.12%
Sep 30, 2013 -9.09%
Jun 30, 2013 -5.38%
Mar 31, 2013 25.56%
Dec 31, 2012 -22.44%
Sep 30, 2012 -20.11%
Jun 30, 2012 -14.10%
Mar 31, 2012 -29.54%
Dec 31, 2011 -4.03%
Sep 30, 2011 32.08%